Moser AB - Search Results

1

Distinction between peroxisomal bifunctional enzyme and acyl-CoA oxidase deficiencies.

Watkins PA, McGuinness MC, Raymond GV, Hicks BA, Sisk JM, Moser AB, Moser HW. Watkins PA, et al. Among authors: moser hw, moser ab. Ann Neurol. 1995 Sep;38(3):472-7. doi: 10.1002/ana.410380322. Ann Neurol. 1995. PMID: 7668838

2

Peroxisomal bifunctional enzyme deficiency.

Watkins PA, Chen WW, Harris CJ, Hoefler G, Hoefler S, Blake DC Jr, Balfe A, Kelley RI, Moser AB, Beard ME, et al. Watkins PA, et al. Among authors: moser ab. J Clin Invest. 1989 Mar;83(3):771-7. doi: 10.1172/JCI113956. J Clin Invest. 1989. PMID: 2921319 Free PMC article.

3

Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups.

Moser AB, Rasmussen M, Naidu S, Watkins PA, McGuinness M, Hajra AK, Chen G, Raymond G, Liu A, Gordon D, et al. Moser AB, et al. J Pediatr. 1995 Jul;127(1):13-22. doi: 10.1016/s0022-3476(95)70250-4. J Pediatr. 1995. PMID: 7541833

4

Complementation analysis of patients with intact peroxisomes and impaired peroxisomal beta-oxidation.

McGuinness MC, Moser AB, Poll-The BT, Watkins PA. McGuinness MC, et al. Among authors: moser ab. Biochem Med Metab Biol. 1993 Apr;49(2):228-42. doi: 10.1006/bmmb.1993.1025. Biochem Med Metab Biol. 1993. PMID: 8484962 Free article.

5

Very long-chain fatty acids in diagnosis, pathogenesis, and therapy of peroxisomal disorders.

Moser HW, Moser AB. Moser HW, et al. Among authors: moser ab. Lipids. 1996 Mar;31 Suppl:S141-4. doi: 10.1007/BF02637066. Lipids. 1996. PMID: 8729109 Review.

6

Neuronal migration abnormality in peroxisomal bifunctional enzyme defect.

Kaufmann WE, Theda C, Naidu S, Watkins PA, Moser AB, Moser HW. Kaufmann WE, et al. Among authors: moser hw, moser ab. Ann Neurol. 1996 Feb;39(2):268-71. doi: 10.1002/ana.410390218. Ann Neurol. 1996. PMID: 8967760

7

Peroxisomal disorders: overview.

Moser HW, Moser AB. Moser HW, et al. Among authors: moser ab. Ann N Y Acad Sci. 1996 Dec 27;804:427-41. doi: 10.1111/j.1749-6632.1996.tb18634.x. Ann N Y Acad Sci. 1996. PMID: 8993562 Review. No abstract available.

8

Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls.

Moser AB, Kreiter N, Bezman L, Lu S, Raymond GV, Naidu S, Moser HW. Moser AB, et al. Among authors: moser hw. Ann Neurol. 1999 Jan;45(1):100-10. doi: 10.1002/1531-8249(199901)45:1<100::aid-art16>3.0.co;2-u. Ann Neurol. 1999. PMID: 9894883

9

Pharmacological induction of peroxisomes in peroxisome biogenesis disorders.

Wei H, Kemp S, McGuinness MC, Moser AB, Smith KD. Wei H, et al. Among authors: moser ab. Ann Neurol. 2000 Mar;47(3):286-96. Ann Neurol. 2000. PMID: 10716247

10

Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening.

Bezman L, Moser AB, Raymond GV, Rinaldo P, Watkins PA, Smith KD, Kass NE, Moser HW. Bezman L, et al. Among authors: moser hw, moser ab. Ann Neurol. 2001 Apr;49(4):512-7. Ann Neurol. 2001. PMID: 11310629

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters